-
Mashup Score: 0
Bulevirtide was safe and increased the proportion of patients with undetectable hepatitis D virus RNA among those in both the 2 mg and 10 mg dosage groups, according to data published in The New England Journal of Medicine. The results were also presented during the EASL Congress.
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 4Novartis Bolsters Neuro Pipeline, RNA Capabilities with Up-to-$1B DTx Pharma Acquisition - 10 month(s) ago
Novartis has acquired DTx Pharma for up to $1 billion, aiming to strengthen its neuroscience pipeline and expand its capabilities in RNA therapeutics.
Categories: Future of Medicine, Latest HeadlinesTweet-
.@Novartis has acquired @DTxPharma for up to $1 billion, aiming to strengthen its #neuroscience pipeline and expand its capabilities in #RNA therapeutics. Learn more: https://t.co/qCcaru9O7d https://t.co/Suu9Bl7jwa
-
-
Mashup Score: 0
Dengue Fever and Betacoronavirus infections are widespread and dangerous. The cofounder and CEO of Emergex answers questions about them and upcoming Phase II and Phase III studies.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Need information on Dengue Fever and Betacoronavirus? ICT asked Emergex's CEO for updates on Phase II and III studies. https://t.co/PmQefBpFYV @EmergexVaccines #dengue #MERS #SARS_CoV_2 #mosquitoborne #RNA
-
-
Mashup Score: 2
Dengue Fever and Betacoronavirus infections are widespread and dangerous. The cofounder and CEO of Emergex answers questions about them and upcoming Phase II and Phase III studies.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
Dengue Fever and Betacoronavirus infections are widespread and dangerous. The cofounder and CEO of Emergex answers questions about them and upcoming Phase II and Phase III studies. https://t.co/NsO8ffBPOJ @EmergexVaccines #dengue #MERS #SARS_CoV_2 #mosquitoborne #RNA
-
-
Mashup Score: 3AI Predicts Activity of RNA-Targeting CRISPR Tools - 10 month(s) ago
The team suggests TIGER tech could pave the way to the development of precise gene controls for use in CRISPR-based therapies.
Categories: Future of Medicine, Latest HeadlinesTweet-
RT @GenomeScience: AI Predicts Activity of RNA-Targeting #CRISPR Tools #AI #deeplearning #RNA https://t.co/RE6cp0vWcU via @GENbio
-
-
Mashup Score: 0Octopuses Can Rewire Their 'Brains' by Editing Their Own RNA on The Fly - 11 month(s) ago
Octopuses have found an incredible way to protect the more delicate features of their nervous system against radically changing temperatures.
Source: ScienceAlertCategories: Healthcare Professionals, Latest HeadlinesTweet-
#Octopuses Can Rewire Their 'Brains' by Editing Their Own #RNA on The Fly : @ScienceAlert https://t.co/9bsJCFTQcg
-
-
Mashup Score: 1RNA Therapies Small Beginnings to Big Opportunities - 11 month(s) ago
Cytiva considers how RNA therapeutics will impact genomic medicine and cell and gene therapies.
Categories: Future of Medicine, Latest HeadlinesTweet-
#RNA Therapies Small Beginnings to Big Opportunities @Cytiva considers how RNA therapeutics will impact genomic medicine and cell and gene therapies. Learn more: https://t.co/1I60mqGjUi https://t.co/LjKwn3WoFz
-
-
Mashup Score: 14Aberrant splicing prediction across human tissues - Nature Genetics - 11 month(s) ago
AbSplice predicts aberrant splicing for 50 human tissues by integrating sequence-based deep learning models, DNA variation and RNA-seq obtained from accessible tissues.
Source: NatureCategories: General Medicine News, Latest HeadlinesTweet-
Study: Novel algorithm 6 times more reliable at predicting defective #RNA @TU_Muenchen @NatureGenet https://t.co/PF5aeV1trV https://t.co/tG9iCamT5j
-
-
Mashup Score: 2
An IDSA Reading Room selection
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: #Myxovirus resistance proteins have antiviral activity against multiple #RNA viruses, including #influenza viruses. #InfectiousDisease @IDSAInfo https://t.co/pjLXbT29C9 https://t.co/bPZ3I2gl4A
-
-
Mashup Score: 2RNA Therapies Small Beginnings to Big Opportunities - 11 month(s) ago
Cytiva considers how RNA therapeutics will impact genomic medicine and cell and gene therapies.
Categories: Future of Medicine, Latest HeadlinesTweet-
#RNA Therapies Small Beginnings to Big Opportunities @Cytiva considers how RNA therapeutics will impact genomic medicine and cell and gene therapies. Learn more: https://t.co/1I60mqGjUi https://t.co/0zVPFsqY6W
-
#Bulevirtide was safe and increased the proportion of #patients with undetectable #hepatitisDvirus #RNA among those in both the 2 mg and 10 mg dosage groups, according to data published in @NEJM #EASLCongress #LiverTwitter https://t.co/aq8xL2LOqQ